Trials / Terminated
TerminatedNCT00463801
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
A Multicentre, Open Label, Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections (cSSTI) Caused by Methicillin-resistant Staphylococcus Aureus (MRSA)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Daptomycin |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-11-01
- First posted
- 2007-04-20
- Last updated
- 2011-03-24
- Results posted
- 2010-12-23
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00463801. Inclusion in this directory is not an endorsement.